[Chemotherapy by intra-arterial path in cancer of the "head and neck" region].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D005153:Facial Neoplasms / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008048:Lip Neoplasms / Q000188:drug therapy; D008441:Maxillary Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D012468:Salivary Gland Neoplasms / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy; D014062:Tongue Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D001761:Bleomycin; D005472:Fluorouracil; D008727:Methotrexate
La chmiothérapie par voie intra-artérielle dans les cancers de la région "tête et cou".